Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Clementine Nordon, Constance Battin, Helene Verdoux, Josef Maria Haro, Mark Belger, Lucien Abenhaim & Tjeerd Pieter van Staa. (2017) The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs. Clinical Epidemiology 9, pages 689-698.
Read now
Read now
James
M. DuBois, Emily
E. Anderson, John Chibnall, Kelly Carroll, Tyler Gibb, Chiji Ogbuka & Timothy Rubbelke. (2013) Understanding Research Misconduct: A Comparative Analysis of 120 Cases of Professional Wrongdoing. Accountability in Research 20:5-6, pages 320-338.
Read now
Read now
Craig Van Dyke. (2013) Research Policies for Schizophrenia in the Global Health Context. International Journal of Mental Health 42:1, pages 51-76.
Read now
Read now
JamesM. DuBois, Holly Bante & WhitneyB. Hadley. (2011) Ethics in Psychiatric Research: A Review of 25 Years of NIH-Funded Empirical Research Projects. AJOB Primary Research 2:4, pages 5-17.
Read now
Read now
Natascha Wilson & Jean
Lud Cadet. (2009) Comorbid Mood, Psychosis, and Marijuana Abuse Disorders: A Theoretical Review. Journal of Addictive Diseases 28:4, pages 309-319.
Read now
Read now
Articles from other publishers (28)
Merve DEMİR & Tolga KÖSKÜN. (2023) Efficacy of Virtual Reality Exposure Therapy in the Treatment of Specific Phobias: A Systematic ReviewÖzgül Fobilerde Sanal Gerçeklik ile Maruz Bırakma Terapisinin Etkinliği: Sistematik Bir Gözden Geçirme. Psikiyatride Güncel Yaklaşımlar 15:4, pages 562-576.
Crossref
Crossref
Elliot Marseille, Stefano Bertozzi & James G. Kahn. (2022) The economics of psychedelic-assisted therapies: A research agenda. Frontiers in Psychiatry 13.
Crossref
Crossref
Carolin Schneider, Johanna Breilmann, Benedikt Reuter, Thomas Becker & Markus Kösters. (2021) Systematic evaluation of the ‘efficacy‐effectiveness gap’ in the treatment of depression with venlafaxine and duloxetine. Acta Psychiatrica Scandinavica 144:2, pages 113-124.
Crossref
Crossref
Jung-Seo Yi. (2019) History and Future of Antipsychotic Drugs. Journal of Korean Neuropsychiatric Association 58:1, pages 2.
Crossref
Crossref
Philip Boyce, Lauren Irwin, Grace Morris, Amber Hamilton, Roger Mulder, Gin S Malhi & Richard J Porter. (2018) Long‐acting injectable antipsychotics as maintenance treatments for bipolar disorder—A critical review of the evidence. Bipolar Disorders 20:S2, pages 25-36.
Crossref
Crossref
A. Fiorillo, M. Luciano & G. Sampogna. (2018) Being influential or being misleading? Citation bias in psychiatric research and practice. Epidemiology and Psychiatric Sciences 27:3, pages 242-243.
Crossref
Crossref
Aminata Ali, Arnaud Carre, Massimiliano Orri, Mathieu Urbach, Caroline Barry, Christine Hassler, Bruno Falissard, Sylvie Berthoz & Clementine Nordon. (2017) The real-life effectiveness of psychosocial therapies on social autonomy in schizophrenia patients: Results from a nationwide cohort study in France. Psychiatry Research 247, pages 97-104.
Crossref
Crossref
T.M. Lincoln, E. Jung, M. Wiesjahn & B. Schlier. (2020) What is the minimal dose of cognitive behavior therapy for psychosis? An approximation using repeated assessments over 45 sessions. European Psychiatry 38, pages 31-39.
Crossref
Crossref
Clementine Nordon, Helene Karcher, Rolf H.H. Groenwold, Mikkel Zöllner Ankarfeldt, Franz Pichler, Helene Chevrou-Severac, Michel Rossignol, Adeline Abbe & Lucien Abenhaim. (2016) The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization. Value in Health 19:1, pages 75-81.
Crossref
Crossref
Somaia Mohamed, Gary R. Johnson, Julia E. Vertrees, Peter D. Guarino, Kimberly Weingart, Ilanit Tal Young, Jean Yoon, Theresa C. Gleason, Katherine A. Kirkwood, Amy M. Kilbourne, Martha Gerrity, Stephen Marder, Kousick Biswas, Paul Hicks, Lori L. Davis, Peijun Chen, AlexandraMary Kelada, Grant D. Huang, David D. Lawrence, Mary LeGwin & Sidney Zisook. (2015) The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations. Psychiatry Research 229:3, pages 760-770.
Crossref
Crossref
Sandra Christiansen, Tim P. Jürgens & Regine Klinger. (2015) Outpatient Combined Group and Individual Cognitive-Behavioral Treatment for Patients With Migraine and Tension-Type Headache in a Routine Clinical Setting. Headache: The Journal of Head and Face Pain 55:8, pages 1072-1091.
Crossref
Crossref
Andrew A. Nierenberg. 2015. Clinical Trial Design Challenges in Mood Disorders. Clinical Trial Design Challenges in Mood Disorders
23
28
.
Samantha Garbers, Kathleen Flandrick, Dayana Bermudez, Allison Meserve & Mary Ann Chiasson. (2014) Improving Contraceptive Choice. Health Promotion Practice 15:6, pages 894-903.
Crossref
Crossref
W. V. Bobo, J. Pathak, H. M. Kremers, B. P. Yawn, S. M. Brue, C. J. Stoppel, P. E. Croarkin, J. St Sauver, M. A. Frye & W. A. Rocca. (2014) An electronic health record driven algorithm to identify incident antidepressant medication users. Journal of the American Medical Informatics Association 21:5, pages 785-791.
Crossref
Crossref
Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori & Nakao Iwata. (2013) Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia. BMC Psychiatry 13:1.
Crossref
Crossref
Erik Johnsen & Rune A. Kroken. (2012) Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness. Therapeutic Advances in Chronic Disease 3:6, pages 287-300.
Crossref
Crossref
Marcel P. Dijkers, Susan L. Murphy & Jason Krellman. (2012) Evidence-Based Practice for Rehabilitation Professionals: Concepts and Controversies. Archives of Physical Medicine and Rehabilitation 93:8, pages S164-S176.
Crossref
Crossref
Michael Riedel, Stefan Leucht, Eckart Rüther, Max Schmauß & Hans-Jürgen Möller. (2011) Critical trial-related criteria in acute schizophrenia studies. European Archives of Psychiatry and Clinical Neuroscience 262:2, pages 151-155.
Crossref
Crossref
Lia van Rijswijk & Mikel Gray. (2012) Evidence, Research, and Clinical Practice. Journal of Wound, Ostomy & Continence Nursing 39:1, pages 35-44.
Crossref
Crossref
Christopher Hautmann, Petra Stein, Ilka Eichelberger, Charlotte Hanisch, Julia Plück, Daniel Walter & Manfred Döpfner. (2010) The Severely Impaired Do Profit Most: Differential Effectiveness of a Parent Management Training for Children with Externalizing Behavior Problems in a Natural Setting. Journal of Child and Family Studies 20:4, pages 424-435.
Crossref
Crossref
John S. March. (2011) Looking to the future of research in pediatric anxiety disorders. Depression and Anxiety 28:1, pages 88-98.
Crossref
Crossref
LEANNE HIDES, SHARON SAMET & DAN I. LUBMAN. (2010) Cognitive behaviour therapy (CBT) for the treatment of co-occurring depression and substance use: Current evidence and directions for future research. Drug and Alcohol Review 29:5, pages 508-517.
Crossref
Crossref
Thomas W. FrazierEric A. YoungstromTravis HaycookAletta SinoffFrancine DimitriouJulie KnappLeslie Sinclair. (2010) Effectiveness of Medication Combined with Intensive Behavioral Intervention for Reducing Aggression in Youth with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology 20:3, pages 167-177.
Crossref
Crossref
Rob Herbert. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
18
.
John Kelly. 2010. Principles of CNS Drug Development. Principles of CNS Drug Development
87
125
.
Elizabeth H. Logue. (2010) Geffen Faculty Highlight Concerns Linking CAIM and Conventional Researchers at UCLA Symposium. Evidence-Based Complementary and Alternative Medicine 7:1, pages 29-32.
Crossref
Crossref
Laura L. Zettler, Mark R. Speechley, Norine C. Foley, Katherine L. Salter & Robert W. Teasell. (2010) A scale for distinguishing efficacy from effectiveness was adapted and applied to stroke rehabilitation studies. Journal of Clinical Epidemiology 63:1, pages 11-18.
Crossref
Crossref
Jorge Mestre-Ferrandiz, Patricia Deverka, Michele Pistallato & Emily Rosenberg. (2014) The Current Drug Development Paradigm: Responding to US and European Demands for Evidence of Comparative Effectiveness and Relative Effectiveness. SSRN Electronic Journal.
Crossref
Crossref